Basic Information
| LncRNA/CircRNA Name | lncRNA-EBIC |
| Synonyms | TMPOP2, lncRNA-EBIC, EBIC |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | Microarray, qPCR, RNAi, Western blot, RIP etc. |
| Sample | cervical cancer tissues, cell lines (HeLa, SiHa, CaSki) |
| Expression Pattern | up-regulated |
| Function Description | lncRNA-EBIC was upregulated in cervical cancer. lncRNA-EBIC was an oncogenic lncRNA, which could promote tumor cell invasion in CC by binding to EZH2 and inhibiting E-cadherin expression. |
| Pubmed ID | 25007342 |
| Year | 2014 |
| Title | Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. |
External Links
| Links for lncRNA-EBIC | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |